Amalgamated Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-14,281
| Closed | -$54K | – | 1725 |
|
|
2018
Q2 | $54K | Buy |
14,281
+2,418
| +20% | +$9.14K | ﹤0.01% | 1695 |
|
|
2018
Q1 | $49K | Sell |
11,863
-329
| -3% | -$1.36K | ﹤0.01% | 1571 |
|
|
2017
Q4 | $57K | Buy |
12,192
+752
| +7% | +$3.52K | ﹤0.01% | 1604 |
|
|
2017
Q3 | $81K | Buy |
11,440
+893
| +8% | +$6.32K | ﹤0.01% | 1525 |
|
|
2017
Q2 | $76K | Buy |
+10,547
| New | +$76K | ﹤0.01% | 1529 |
|
|
2016
Q2 | – | Sell |
-10,906
| Closed | -$51K | – | 1414 |
|
|
2016
Q1 | $51K | Buy |
+10,906
| New | +$51K | 0.01% | 1255 |
|
|
2015
Q4 | – | Sell |
-10,912
| Closed | -$38K | – | 1289 |
|
|
2015
Q3 | $38K | Buy |
10,912
+194
| +2% | +$676 | ﹤0.01% | 1274 |
|
|
2015
Q2 | $107K | Buy |
10,718
+571
| +6% | +$5.7K | 0.01% | 1300 |
|
|
2015
Q1 | $129K | Buy |
+10,147
| New | +$129K | 0.02% | 900 |
|